ALS: Disease or syndrome?

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 7, 2011, Pages 711-

  Van Den Berg, Leonard H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RILUZOLE;

AMYOTROPHIC LATERAL SCLEROSIS; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG TREATMENT FAILURE; EDITORIAL; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; LIFESTYLE; MOLECULAR MECHANICS; MOTOR NEURON DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 79959870779     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2011.241513     Document Type: Editorial

References (5)

1. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942-55.
2. Beghi E, Chiò A, Couratier P, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler 2011;12:1-10.
3. O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 2008;79:30-2.
4. Chio A, Calvo A, Moglia C, et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82:740-46.
5. Van den Berg-Vos RM, Visser J, Kalmijn S, et al. A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes. Arch Neurol 2009;66:751-7.